Abstract | OBJECTIVE: METHODS: The effect of STS on cytotoxicity was evaluated using the 3-(4,5-dimethylthiazol-2-yl)-3,5-phenytetrazoliumromide (MTT) assay. As indexes for cardiocyte hypertrophy, cell size was determined by phase contrast microscopy and protein synthesis rate was measured by 3H-leucine incorporation. The proto-oncogene c-fos mRNA expression of cardiocytes was assessed using reverse transcription polymerase chain reaction (RT-PCR). RESULTS: STS could inhibit cardiocyte hypertrophy, increase the protein synthesis rate and enhance proto-oncogene c-fos mRNA expression in cardiocytes induced by Ang II (P<0.01), with an effect similar to that of Valsartan, the Ang II receptor antagonist. CONCLUSION: STS can prevent the hypertrophy of cardiac myocytes induced by Ang II, which may be related to its inhibition of the expression of proto-oncogene c-fos mRNA.
|
Authors | Jun Feng, Zhi Zheng |
Journal | Chinese journal of integrative medicine
(Chin J Integr Med)
Vol. 14
Issue 3
Pg. 197-201
(Sep 2008)
ISSN: 1672-0415 [Print] China |
PMID | 18853116
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Phenanthrenes
- Proto-Oncogene Proteins c-fos
- RNA, Messenger
- Tritium
- Angiotensin II
- tanshinone II A sodium sulfonate
- Leucine
|
Topics |
- Angiotensin II
(pharmacology)
- Animals
- Animals, Newborn
- Cell Survival
(drug effects)
- Gene Expression Regulation
(drug effects)
- Hypertrophy
- Leucine
(metabolism)
- Myocytes, Cardiac
(drug effects, pathology)
- Phenanthrenes
(pharmacology)
- Proto-Oncogene Proteins c-fos
(genetics, metabolism)
- RNA, Messenger
(genetics, metabolism)
- Rats
- Rats, Wistar
- Time Factors
- Tritium
|